KOSPI

Folgen
Illustration of Seoul's KOSPI stock index falling amid U.S.-Iran peace talks prospects, showing concerned traders and declining market charts.
Bild generiert von KI

Seoul stocks open lower amid U.S.-Iran peace talks prospects

Von KI berichtet Bild generiert von KI

Seoul stocks opened lower on Thursday amid prospects for U.S.-Iran peace talks. The KOSPI fell 80.19 points, or 1.42 percent, to 5,562.02.

Seoul stocks opened sharply higher on Wednesday amid growing optimism over Washington's moves to end the month-long war in Iran. The benchmark KOSPI rose 170.22 points, or 3.06 percent, to 5,724.14 in the first 15 minutes of trading.

Von KI berichtet

Extreme KOSPI swings after U.S. and Israeli airstrikes on Iran are worsening the 'Korea discount', says Peter S. Kim of KB Financial Group. The index plunged 7.24% on March 3 and surged a record 9.63% on March 5. Kim blames retail investors' short-term, high-risk trading.

Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.

Von KI berichtet

Seoul shares extended losses late Thursday morning as foreign investors offloaded major chipmakers. The KOSPI fell 1.12 percent to 3,987.46 as of 11:20 a.m. This came after a gain the previous day driven by positive third-quarter GDP data.

Mittwoch, 18. März 2026, 00:18 Uhr

Seoul shares open nearly 3% higher on tech boost

Freitag, 27. Februar 2026, 03:56 Uhr

Seoul shares sharply down late Friday morning on profit-taking

Dienstag, 17. Februar 2026, 21:37 Uhr

Number of firms with over 1 trillion won market cap surges on stock rally

Montag, 02. Februar 2026, 10:02 Uhr

KOSPI surges trigger buy-side circuit breaker

Freitag, 23. Januar 2026, 17:36 Uhr

Seoul shares rise for third day to close near 5,000

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen